Results 181 to 190 of about 2,208 (222)
Some of the next articles are maybe not open access.
La Ricerca in Clinica e in Laboratorio, 1984
A woman with multicentric reticulohistiocytosis, having symptoms including bleeding and a borderline level of factor VIII, was given an i.v. infusion of DDAVP as a pharmacological test to evaluate the release of factor VIII-related properties from storage sites.
Ugo Taddeo +3 more
openaire +3 more sources
A woman with multicentric reticulohistiocytosis, having symptoms including bleeding and a borderline level of factor VIII, was given an i.v. infusion of DDAVP as a pharmacological test to evaluate the release of factor VIII-related properties from storage sites.
Ugo Taddeo +3 more
openaire +3 more sources
Effect of 1-Deamino-8-D-Arginine Vasopressin on the Prolonged Bleeding Time in Chronic Renal Failure
Nephron, 1982The prolonged bleeding times of 12 patients with chronic renal failure were significantly shortened at 1 and 2 h after an infusion of 0.4 microgram/kg 1-deamino-8-D-arginine vasopressin (DDAVP). In 5 of these patients, the bleeding times 24 h after infusion had returned to approximate baseline values, suggesting that the effect of DDAVP is a temporary ...
A.J.S. Watson, J.A.B. Keogh
openaire +3 more sources
1-Deamino-8-<i>D</i>-Arginine Vasopressin as a Therapy for the Bleeding Diathesis of Renal Failure
American Journal of Nephrology, 1984The treatment of the bleeding diathesis of renal failure remains unsatisfactory. 1-Deamino-8-D-arginine vasopressin (DDAVP) has recently been shown to shorten the prolonged bleeding time of renal failure and may as a result diminish the risk of clinical hemorrhage. We describe 2 cases where DDAVP was used successfully in the management of hemorrhage in
A.J. Watson, J.A.B. Keogh
openaire +3 more sources
Response to 1-Deamino-8-<i>D</i>-Arginine Vasopressin in von Willebrand Disease
Pathophysiology of Haemostasis and Thrombosis, 1994The synthetic agent, l-deamino-8-<i>D</i>-arginine vasopressin (DDAVP), is generally regarded to be the treatment of choice for persons with type I von Willebrand disease (vWD), and may be useful in type IIA vWD as well. Several formulations of the drug are available, including a highly concentrated intranasal spray formulation which is ...
openaire +3 more sources
Effect of Two-Week Infusion of Deamino <i>D</i><i>-</i>Arginine Vasopressin in Rats
Hormone Research, 1987Our purpose was to investigate a method of prolonged desmopressin (DDAVP) infusion in a free roaming rat to better understand the SIADH (syndrome of inappropriate antidiuretic hormone secretion) syndrome in man. DDAVP was infused for 2 weeks from implanted self-powered osmotic minipumps.
Hans Mokry +3 more
openaire +3 more sources
Antiproliferative Effect of 1-Deamino-8-
Desmopressin (dDAVP), a synthetic nonapeptide derivative of arginine vasopressin, is a safe antidiuretic and hemostatic compound that acts as a selective agonist for the vasopressin V2 membrane receptor (V2R). It is known that dDAVP can inhibit progression of residual metastatic cells in preclinical models.
Juan Garona +6 more
openaire +3 more sources
Journal of Urology, 1994
A case of familial central diabetes insipidus and dilatation of the urinary tract is reported. Administration of desmopressin for 1 year improved urinary tract dilatation with a concomitant reduction in urine volume. Urinary cyclic adenosine monophosphate and prostaglandin E2 excretion increased after treatment.
Yoshio Aso +5 more
openaire +3 more sources
A case of familial central diabetes insipidus and dilatation of the urinary tract is reported. Administration of desmopressin for 1 year improved urinary tract dilatation with a concomitant reduction in urine volume. Urinary cyclic adenosine monophosphate and prostaglandin E2 excretion increased after treatment.
Yoshio Aso +5 more
openaire +3 more sources
Effect of 1‐Deamino‐8‐
The influence of 1-deamino-8-D-arginine vasopressin (DDAVP), the new antidiutetic polypeptide without any side effects on plasma cortisol, was investigated in 30 healthy persons. A dose of 4 mug DDAVP administered intravenously induced a rise in plasma cortisol (hydrocortisone) levels greater than 3.5 mug/100 ml in 12 out of 20 persons studied. In this
János P. Radó, Eva Juhos
openaire +2 more sources
The Lancet, 1977
1-Deamino-8-d-arginine vasopressin (D.D.A.V.P.) infusion causes a marked increase in factor-VIII (antihaemophilic-factor)-related properties in patients with moderate and mild haemophilia and von Willebrand's disease (vWd). The possibility was therefore evaluated that such an autologous factor-VII response might be haemostatically effective, allowing ...
Zaverio M. Ruggeri +3 more
openaire +3 more sources
1-Deamino-8-d-arginine vasopressin (D.D.A.V.P.) infusion causes a marked increase in factor-VIII (antihaemophilic-factor)-related properties in patients with moderate and mild haemophilia and von Willebrand's disease (vWd). The possibility was therefore evaluated that such an autologous factor-VII response might be haemostatically effective, allowing ...
Zaverio M. Ruggeri +3 more
openaire +3 more sources